Penetration of Ibrexafungerp (Formerly SCY-078) at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model

Ibrexafungerp (IBX), formerly SCY-078, is a novel, oral and intravenous, semisynthetic triterpenoid glucan synthase inhibitor in clinical development for treating multiple fungal infections, including invasive candidiasis. Intra-abdominal candidiasis (IAC) is one of the most common types of invasive...

全面介紹

Na minha lista:
書目詳細資料
發表在:Antimicrob Agents Chemother
Main Authors: Lee, Annie, Prideaux, Brendan, Zimmerman, Matthew, Carter, Claire, Barat, Stephen, Angulo, David, Dartois, Véronique, Perlin, David S., Zhao, Yanan
格式: Artigo
語言:Inglês
出版: American Society for Microbiology 2020
主題:
Pharmacology
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7038262/
https://ncbi.nlm.nih.gov/pubmed/31871074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02268-19
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍